Author:
Gunsch Matthew J.,Schwalm Erica L.,Ouimet Claire M.,Halsey Holst M.,Hamilton Simon E.,Bernardoni Frank,Jo Junyong
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference27 articles.
1. World Heath Organization: HIV data and statistics. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics, (accessed 10 November 2021.).
2. Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1;Markowitz;Curr. Opin. HIV AIDS,2020
3. Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial;Matthews;Nat. Med.,2021
4. Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial;Molina;Lancet HIV,2021
5. Design of an in vitro biocatalytic cascade for the manufacture of islatravir;Huffman;Science,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献